REEF
MSC_INT_SUP1
CARGILL
Cargill Empyreal75
syndel

Syndel’s Syncaine ® approved in the UK

REEF
MSC_INT_SUP
CARGILL
Cargill Empyreal75

On March 22, 2022, Syndel’s tricaine methanesulfonate (MS-222) fish anesthetic Syncaine ® received a Marketing Authorization from the United Kingdom’s Veterinary Medicines Directorate (VMD). 

Syncaine ®, formally known as Tricaine-S and Aqualife TMS, is manufactured at Syndel’s new US production facility. 

Since its initial US FDA approval in 1997, Syndel’s Tricaine has become a recognized and highly regarded fish anesthetic that is widely used in the global aquaculture industry. 

syndel

Founded in 1972, Syndel is dedicated to delivering fish health solutions for the aquaculture Industry.

From Syndel’s head office located in Ferndale, Washington USA, Syndel manufactures and markets a portfolio of products that are specifically dedicated to fish health, nutrition, reproduction, and biosecurity

For more information, please visit www.syndel.com or contact us at sales@syndel.com

REEF
MSC_INT_INF
CARGILL
Cargill Empyreal75

Leave a comment

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *